BlackRock Fund Advisors - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 10 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$2,000
-33.3%
6570.0%0.00%
Q3 2016$3,000
+50.0%
657
+9.5%
0.00%
Q2 2016$2,000
+100.0%
600
+11.9%
0.00%
Q1 2016$1,0005360.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
VANGUARD GROUP INC 38,947$79,0000.00%
UBS Group AG 2,220$4,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 80$00.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
DEUTSCHE BANK AG\ 5,691$11,0000.00%
CITIGROUP INC 5,504$11,0000.00%
MORGAN STANLEY 100$00.00%
MSI Financial Services Inc 24$00.00%
Renaissance Technologies 19,924$40,0000.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders